VIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451.
Published September 3, 2014 · Recall initiated: March 4, 2014
Summary
FDA records drug Class II recall D-1556-2014, published September 3, 2014 and initiated March 4, 2014. Recalling firm: Alkermes, Inc.; Status: Terminated; Reported quantity: 4,364 vials; Lot: Batch Number: 412-3732AA; expiration date 07/2016 (NDC# 65757-302-02; Kit Pacaging Lot Number: 2013-021; expiration date 07/2016 (NDC# 65757-300-01. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Customer complaints for failure to deliver the dose.
What to do
Voluntary: Firm initiated · Letter
Get an email if VIVITROL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VIVITROL
- Manufacturer
- Alkermes, Inc.
- Distributor
- Nationwide
- Lot
- Batch Number: 412-3732AA; expiration date 07/2016 (NDC# 65757-302-02; Kit Pacaging Lot Number: 2013-021; expiration date 07/2016 (NDC# 65757-300-01.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) OneOctober 9, 2019
- FDAFamotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection,September 3, 2014
- FDADiltiazem HCl Extended Release Capsules, USP 120 mg, 500 count bottles, Rx only, Mylan Pharmaceuticals, Inc.,September 3, 2014
- FDANicotine Polacrilex Lozenge, 2 mg Mint Mini. 27 Ct Tubes, Over the Counter. Perrigo, 502 Eastern Ave, PlantSeptember 3, 2014
- FDAPhilips IntelliSpace ECG Management System, with software option C61 needed to import ECGs from the QuintonAugust 27, 2014
- FDAVIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mgJuly 31, 2013
Questions about this recall
Was VIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451. recalled?
Yes. FDA published recall D-1556-2014 on September 3, 2014. Reported hazard: Customer complaints for failure to deliver the dose.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VIVITROL.